Biocybernetics SPRL
Ouverture de failliteBiocybernetics reported total assets of 509,897 € at the end of the 2016 financial year (annual accounts filed with the NBB on 17 May 2018).
The score of Biocybernetics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2016
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biocybernetics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2016filed on 17 May 2018
- Year ended 31 Dec 2015filed on 16 Jan 2018
- Year ended 31 Dec 2014filed on 14 Dec 2016
- Year ended 31 Dec 2013filed on 29 Sep 2014
- Year ended 31 Dec 2012filed on 30 Aug 2013
Biocybernetics's financial analysis
- Solvency-1.6%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biocybernetics
Biocybernetics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0452.327.727
- VAT number
- BE0452327727
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 31 Mar 1994
- Registered office
- 4750 Bütgenbach
- Latest accounts
- 2016 · filed on 17 May 2018
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Biocybernetics (SPRL) has been based in Bütgenbach since 1994, active in: manufacture of other pharmaceutical products. For 2016, it reports a net loss of 23,840 € and equity of −8,096 €; its revenue is not published. Its solvency stands at -1.6%, below the median of its sector (34.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biocybernetics
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Thameus Manufacture of pharmaceutical preparations Liège · balance sheet 502,659 €
- Unda Manufacture of pharmaceutical preparations Aywaille · balance sheet 517,605 €
- Honeypatch Manufacture of pharmaceutical preparations Liège · balance sheet 330,409 €
- Rodilo Manufacture of pharmaceutical preparations Liège · balance sheet 204,587 €
- AIP Medical Manufacture of pharmaceutical preparations Olne · balance sheet €1.64m
- Theratopix Pharma Manufacture of pharmaceutical preparations Liège · balance sheet 146,427 €
- ExoXpert Manufacture of pharmaceutical preparations Liège · balance sheet €2.05m
- Astel Medica Manufacture of pharmaceutical preparations Neupré · balance sheet €2.65m
Frequently asked questions about Biocybernetics
What is the revenue of Biocybernetics?
Biocybernetics files its accounts in a format where revenue is optional: it is not published for 2016.
What is the VAT number of Biocybernetics?
In Belgium, the VAT number is the company number prefixed with BE: BE0452327727 for Biocybernetics, if the company is VAT-registered. Its company number (CBE) is 0452.327.727.
Where is the registered office of Biocybernetics?
According to the CBE register, the registered office of Biocybernetics is in 4750 Bütgenbach.
What is the equity of Biocybernetics?
At the close of the 2016 financial year, the equity of Biocybernetics amounts to -8,096 €, a solvency of -1.6% of total assets.
Who manages Biocybernetics?
The register lists 2 active mandates at Biocybernetics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biocybernetics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →